GRAND PHARM. GRP. HD-01 (MX6A F) stock market data APIs
€0.8125
0(0%)
as of January 19, 2026
Try our APIs with
free plan!
GRAND PHARM. GRP. HD-01 Financial Data Overview
Price chart is built with
Anychart
Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additives; disposal surgical products; and Chinese medicine and health food products, as well as engages in the treatment of sewage. The company has a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University in the field of ophthalmic drug research and development. It operates in the People's Republic of China, the rest of Asia, the United States, Europe, and internationally. The company has a business collaboration with the Sirtex Group agreement to enable collaboration on research and development of pharmaceutical products. The company was formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited. The company was incorporated in 1995 and is based in Central, Hong Kong.
Prev. Close
0.8125
Open
0.8125
High
0.8125
Low
0.8125
52 wk Range
0.4717-1.07
Market Cap
3 027 M
P/E Ratio
11.9286
Shares Outstanding
3 502 M
Revenue
11 705 M
Dividends (Yield)
0.3077
Beta
0.896
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GRAND PHARM. GRP. HD-01 data using free add-ons & libraries
Get GRAND PHARM. GRP. HD-01 Fundamental Data
GRAND PHARM. GRP. HD-01 Fundamental data includes:
- Net Revenue: 11 705 M
- EBITDA: 2 450 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GRAND PHARM. GRP. HD-01 News
New
Chinese drug makers put on brave face after report says Trump mulling curbs on US licensing
Chinese drug makers put on a brave face in the wake of a report that said the Trump administration was considering new restrictions on China-developed medicines, citing the country's supply chain and ...
The world's first: Grand Pharma's global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China
The results showed that the SOFA scores of the drug treatment groups on the 7th day were significantly lower than those of the baseline, especially in the high-dose group, where the decrease was signi...
BAIOO Family Interactive Leads Our Trio Of Penny Stock Highlights
Recent global market movements have been characterized by volatility, with U.S. stocks experiencing declines amid geopolitical tensions and consumer spending concerns. In such a climate, investors may...
January 2025's Promising Penny Stocks To Watch
As global markets continue to surge, with U.S. stocks reaching record highs amid optimism over trade policies and AI developments, investors are keenly observing the shifting economic landscape. In th...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
